Find the right life sciences accounts
and the signal that makes them ready now.
Pistachio helps life sciences BD and commercial teams identify who to target, when to reach out, and why now — using real-time signals from clinical trials, publications, conferences, and hiring activity.
Priority Stakeholders
Surfaced from 1,200+ signals across your target marketDavid Lam
VP Data Science · AstraZeneca
His team is actively scaling ML infrastructure for molecular representations — exactly the problem your platform solves.
"Saw your post on scaling molecular representations — we've been working with teams hitting similar limits. Compare notes at Bio-IT?"
Sarah Chen
Head of Computational Bio · Roche
Teams scaling up AI/ML often need external platforms to accelerate — your timing is perfect as she builds.
"Noticed your team is scaling up AI/ML — happy to share what's worked for similar buildouts. Free for coffee at Bio-IT?"
Michael Torres
Dir. External Innovation · Novartis
He's the decision-maker for AI partnerships and has a track record of closing deals with companies like yours.
"Looking forward to your panel — we've helped accelerate a few AI partnerships in this space. Would love to connect after."
9.5 hours of research saved on this page alone —signals updated in real-time
How teams use Pistachio
Right Time
Right Account
Right Stakeholder
Right Messaging
Narrow the market to accounts that matter
The problem: As an early team, everyone could be a customer — which means no one is a priority.
Pistachio: Helps startups narrow a broad pharma and biotech landscape into a focused list of accounts most likely to be receptive right now, based on real activity.
Understand why an account would care today
The problem: Cold outreach sounds generic because timing is unclear.
Pistachio: For each prioritized account, provides clear context on what has changed recently — giving founders a concrete reason to reach out now.
Focus on stakeholders who own the problem
The problem: Reaching the wrong team wastes your best early shots.
Pistachio: Connects account activity to the teams and roles most likely to feel the pain, helping focus on stakeholders who can evaluate and champion a new product.
Reach out with relevance — not a generic pitch
The problem: Early outreach feels risky when every message is a guess.
Pistachio: With account focus, timing context, and stakeholder clarity, teams can reach out with messages that feel informed and relevant — increasing reply rates.
Signal Packs
Pre-built, research-backed lists of companies and decision-makers — with verified activity signals, sources, and contact info. Updated on a schedule so you always have fresh leads.
Submission Sprint
40+ pharma & biotech companies with imminent FDA submissions — regulatory signals, filing timelines, and decision-maker contacts.
AI R&D Leaders
48 pharma AI/ML decision-makers who are actively building, hiring, and investing — with verified activity signals and proof.
GLP-1 Pipeline Radar
45 companies racing to build the next obesity blockbuster — drug candidates, clinical stages, deal signals, and BD contacts.
ASCO GI 2026
52 pharma companies who presented at ASCO GI 2026 — with 156 oncology decision-makers and verified conference signals.
AI Conference Circuit
55 pharma AI leaders who presented at AWS re:Invent, NVIDIA GTC, Google Cloud Next, Bio-IT World in 2025.
AI Consortium Leaders
12 major pharmas shaping AI standards in OpenFold3/AISB & Pistoia Alliance — the decision-makers buying AI tools.